Who Supplies Diazepam? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Diazepam exports, with 75+ registered manufacturers shipping to buyers across 77+ countries — yet a handful of companies dominate the shipments. GLAND PHARMA LTD holds the largest share at 11.1% (export value: $833.6K). Close behind, VENOR PHARMA LIMITED (10.4%, $778.2K). MYLAN LABORATORIES LIMITED (9.5%, $715.4K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Diazepam? Top Manufacturers & Their Buyers
Flow of Diazepam from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Diazepam Supplier Network — Key Market Intelligence
The Diazepam export market from India is led by GLAND PHARMA LTD, which alone commands a 11.1% share, shipping $833.6K worth of product across 4 shipments. The second-largest exporter, VENOR PHARMA LIMITED, contributes $778.2K (10.4%) to the overall market. Combined, the top two suppliers alone account for 21.5% of all Diazepam exports, indicating a relatively concentrated supply base.
Across all 75 tracked manufacturers, the total Diazepam export value stands at $7.5M from 534 shipments. The market average shipment value is $14.0K. The single largest buyer relationship in terms of trade value is LIFE SCIENCE LOGISTICS LLC, receiving $833.6K worth of product.
The combined buyer network spans 19 named purchasing companies, including LIFE SCIENCE LOGISTICS LLC, M/S.MEDICAL STORES DEPARTMENT,, (SOCIETE BENINOISE POUR L' APPROVIS, M S OZBEKISTON DORI , MYLAN PHARMACEUTICALS INC and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1GLAND PHARMA LTD
GLAND PHARMA LTD is the first-largest Diazepam exporter from India, with a market share of 11.1% and a total export value of $833.6K across 4 shipments. Their average shipment value of $208.4K is above the market average of $14.0K, suggesting premium or bulk contract pricing.
GLAND PHARMA LTD serves 1 named buyer in our database. LIFE SCIENCE LOGISTICS LLC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• LIFE SCIENCE LOGISTICS LLC — $833.6K across 4 shipments (100.0% of this supplier's total exports)
Key Insight: GLAND PHARMA LTD's per-shipment value of $208.4K is 1384% above the market average of $14.0K, consistent with large-order contracts or value-added formulations.
2VENOR PHARMA LIMITED
VENOR PHARMA LIMITED is the second-largest Diazepam exporter from India, with a market share of 10.4% and a total export value of $778.2K across 98 shipments. Their average shipment value of $7.9K is below the market average of $14.0K, reflecting a high-volume, competitive pricing strategy.
VENOR PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF — $338.1K across 43 shipments (43.5% of this supplier's total exports)
• TO THE ORDER OF — $177.7K across 22 shipments (22.8% of this supplier's total exports)
• M/S.MEDICAL STORES DEPARTMENT, — $123.1K across 16 shipments (15.8% of this supplier's total exports)
• (SOCIETE BENINOISE POUR L' APPROVIS — $71.4K across 9 shipments (9.2% of this supplier's total exports)
• M S OZBEKISTON DORI — $67.7K across 9 shipments (8.7% of this supplier's total exports)
Key Insight: VENOR PHARMA LIMITED operates with high shipment frequency (98 shipments) at a per-shipment value of $7.9K, indicating a broad distribution network with many smaller, regular orders.
3MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the third-largest Diazepam exporter from India, with a market share of 9.5% and a total export value of $715.4K across 28 shipments. Their average shipment value of $25.5K is above the market average of $14.0K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 2 named buyers in our database. MYLAN PHARMACEUTICALS INC is the dominant customer, accounting for 86.4% of this supplier's tracked business. Top customers include:
• MYLAN PHARMACEUTICALS INC — $618.3K across 24 shipments (86.4% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC — $97.1K across 4 shipments (13.6% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $25.5K is 82% above the market average of $14.0K, consistent with large-order contracts or value-added formulations.
4VERVE HUMAN CARE LABORATORIES
VERVE HUMAN CARE LABORATORIES is the fourth-largest Diazepam exporter from India, with a market share of 4.1% and a total export value of $309.4K across 16 shipments. Their average shipment value of $19.3K is above the market average of $14.0K, suggesting premium or bulk contract pricing.
VERVE HUMAN CARE LABORATORIES serves 5 named buyers in our database. M S PHARMACIE CENTRALE DE is the dominant customer, accounting for 78.5% of this supplier's tracked business. Top customers include:
• M S PHARMACIE CENTRALE DE — $243.0K across 13 shipments (78.5% of this supplier's total exports)
• M S CAMEG-TOGO QUART — $20.5K across 1 shipments (6.6% of this supplier's total exports)
• M S ABACUS PHARMA AF — $16.3K across 1 shipments (5.3% of this supplier's total exports)
• M S PRINCE PHARMA AV — $15.3K across 1 shipments (4.9% of this supplier's total exports)
• M S UNIQUE PHARMAAV — $14.3K across 1 shipments (4.6% of this supplier's total exports)
Key Insight: VERVE HUMAN CARE LABORATORIES's per-shipment value of $19.3K is 38% above the market average of $14.0K, consistent with large-order contracts or value-added formulations.
5SWISS PARENTERALS LIMITED
SWISS PARENTERALS LIMITED is the fifth-largest Diazepam exporter from India, with a market share of 3.0% and a total export value of $222.9K across 27 shipments. Their average shipment value of $8.3K is below the market average of $14.0K, reflecting a high-volume, competitive pricing strategy.
SWISS PARENTERALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• CURAMUS HEALTHIMED — $70.5K across 9 shipments (31.6% of this supplier's total exports)
• SHREEJI PHARMACEUTIC — $58.2K across 7 shipments (26.1% of this supplier's total exports)
• SoBAPS S A — $49.6K across 6 shipments (22.2% of this supplier's total exports)
• PHARMAVET LIMITED — $22.6K across 3 shipments (10.1% of this supplier's total exports)
• HYPERPHARM LTD — $22.0K across 3 shipments (9.9% of this supplier's total exports)
Key Insight: SWISS PARENTERALS LIMITED operates with high shipment frequency (27 shipments) at a per-shipment value of $8.3K, indicating a broad distribution network with many smaller, regular orders.
6CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED
CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED is the fifth-largest Diazepam exporter from India, with a market share of 2.4% and a total export value of $178.6K across 28 shipments. Their average shipment value of $6.4K is below the market average of $14.0K, reflecting a high-volume, competitive pricing strategy.
CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• OPHAM — $85.1K across 13 shipments (47.7% of this supplier's total exports)
• IMRES BV — $48.8K across 8 shipments (27.4% of this supplier's total exports)
• JPS DISTRIBUCIONES E — $21.2K across 3 shipments (11.9% of this supplier's total exports)
• OPHAM SUITED ROUTE D — $12.3K across 2 shipments (6.9% of this supplier's total exports)
• TO THE ORDER — $11.2K across 2 shipments (6.3% of this supplier's total exports)
Key Insight: CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (28 shipments) at a per-shipment value of $6.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Diazepam Flows
Once Diazepam leaves the manufacturing plants of companies like GLAND PHARMA LTD and VENOR PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $7.5M. United States absorbs the largest share at 32.2% ($2.4M), followed by Tanzania (6.7%) and Uzbekistan (6.2%).
In United States — the top destination — named importers include LIFE SCIENCE LOGISTICS LLC, MYLAN PHARMACEUTICALS INC,, M/S. MYLAN PHARMACEUTICALS INC,. In Tanzania, key buyers are M/S.MEDICAL STORES DEPARTMENT,, M/S.JILICHEM (T) LIMITED.
This geographic spread reflects Diazepam's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Diazepam Go? Top Importing Countries & Their Buyers
Trade flow of Diazepam exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Diazepam imports from India, with a total trade value of $2.4M across 34 shipments — representing a 32.2% share of all Diazepam exports. The average shipment value of $71.1K is above the global average of $14.0K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Diazepam importers in United States: LIFE SCIENCE LOGISTICS LLC is the largest buyer, accounting for 34.5% ($833.6K) of this market's total imports.
• LIFE SCIENCE LOGISTICS LLC — $833.6K (34.5% of United States's total)
• MYLAN PHARMACEUTICALS INC, — $618.3K (25.6% of United States's total)
• M/S. MYLAN PHARMACEUTICALS INC, — $544.2K (22.5% of United States's total)
Key Insight: United States's per-shipment average of $71.1K (406% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Diazepam imports from India.
2Tanzania
Tanzania ranks as the second-largest destination for Diazepam imports from India, with a total trade value of $501.8K across 11 shipments — representing a 6.7% share of all Diazepam exports. The average shipment value of $45.6K is above the global average of $14.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Diazepam importers in Tanzania: M/S.MEDICAL STORES DEPARTMENT, is the largest buyer, accounting for 24.5% ($123.1K) of this market's total imports.
• M/S.MEDICAL STORES DEPARTMENT, — $123.1K (24.5% of Tanzania's total)
• M/S.JILICHEM (T) LIMITED — $71.3K (14.2% of Tanzania's total)
Key Insight: Tanzania's per-shipment average of $45.6K (225% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tanzania is a key market for Diazepam imports from India.
3Uzbekistan
Uzbekistan ranks as the third-largest destination for Diazepam imports from India, with a total trade value of $465.4K across 2 shipments — representing a 6.2% share of all Diazepam exports. The average shipment value of $232.7K is above the global average of $14.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Diazepam importers in Uzbekistan: M/S OZBEKISTON DORI-TA MINOTI is the largest buyer, accounting for 53.0% ($246.6K) of this market's total imports.
• M/S OZBEKISTON DORI-TA MINOTI — $246.6K (53.0% of Uzbekistan's total)
Key Insight: Uzbekistan's per-shipment average of $232.7K (1557% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Uzbekistan is a key market for Diazepam imports from India.
4Congo Dr
Congo Dr ranks as the fourth-largest destination for Diazepam imports from India, with a total trade value of $319.2K across 40 shipments — representing a 4.3% share of all Diazepam exports. The average shipment value of $8.0K is below the global average of $14.0K, consistent with generic/API volume purchasing. This market is served by 3 tracked buyers.
Named Diazepam importers in Congo Dr: SHALINA HEALTHCARE SARL is the largest buyer, accounting for 39.0% ($124.6K) of this market's total imports.
• SHALINA HEALTHCARE SARL — $124.6K (39.0% of Congo Dr's total)
• MEDICO PLUS — $78.0K (24.4% of Congo Dr's total)
• PRINCE PHARMA — $74.9K (23.5% of Congo Dr's total)
Key Insight: Congo Dr receives frequent, smaller shipments of Diazepam — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Congo Dr is a key market for Diazepam imports from India.
5Nigeria
Nigeria ranks as the fifth-largest destination for Diazepam imports from India, with a total trade value of $259.2K across 0 shipments — representing a 3.5% share of all Diazepam exports. The average shipment value of $259.2K is above the global average of $14.0K, indicating high-value procurement contracts or branded formulations.
Key Insight: Nigeria's per-shipment average of $259.2K (1747% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Diazepam imports from India.
People Also Ask — Diazepam Supplier & Trade Network
Who are the top suppliers of Diazepam from India?+
Which companies buy Diazepam from Indian manufacturers?+
Where does Diazepam exported from India go?+
What is the market share of the top Diazepam supplier from India?+
What is the average shipment value for Diazepam exports from India?+
Is Diazepam manufactured in India and exported globally?+
Which country imports the most Diazepam from India?+
Who are the buyers of Diazepam in Tanzania?+
How concentrated is the Diazepam supplier market in India?+
How do I find verified buyers for Diazepam in specific countries?+
Diazepam Trade Network — Key Takeaways
- 1GLAND PHARMA LTD is India's dominant Diazepam exporter with a 11.1% market share and $833.6K in total exports — making it the single most important sourcing entity in this market.
- 2The top 75 suppliers collectively account for 40.5% of all tracked Diazepam exports, with a combined trade value of $7.5M.
- 3United States is the largest destination market, absorbing 32.2% of India's Diazepam exports ($2.4M). Tanzania (6.7%) and Uzbekistan (6.2%) follow.
- 4With 534 total shipments averaging $14.0K each, the Diazepam export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include LIFE SCIENCE LOGISTICS LLC, M/S.MEDICAL STORES DEPARTMENT,, (SOCIETE BENINOISE POUR L' APPROVIS, MYLAN PHARMACEUTICALS INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 77 countries
Network value: $7.5M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diazepam — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Diazepam.
- 2.Flow Mapping: 75 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 534 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 77 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
534 Verified Shipments
75 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists